-
Newly adopted flu vaccine could save 1,700 lives
pharmafile
September 13, 2017
The Fluad flu vaccine, produced by Seqirus, was approved by the MHRA for use beginning in 2018 and further data has been released to back up this decision, showing that a potential 1,700 lives could be saved through its use.
-
Improved vaccine protects against nine types of HPV
europeanpharmaceuticalreview
September 08, 2017
Scientists have developed an improved vaccine commonly associated with cervical cancer…
-
Gavi to save 20M lives, $350B with vaccine program by 2020
fiercepharma
September 06, 2017
The good it’s doing will have amounted to 20 million lives, along with $350 billion healthcare costs, saved by 2020, a new study found.
-
New flu vaccine approved for UK use
pharmatimes
August 23, 2017
The Medicines and Healthcare products Regulatory Agency has cleared the adjuvanted trivalent influenza vaccine Fluad for use in people aged 65 years or older
-
"Indian manufacturers account for 60% of vaccine supplies made to UNICEF”
biospectrumasia
August 23, 2017
‘Indian vaccine manufacturers have several products in their R&D pipeline and as they roll out, the dominance of the multinational companies will subside in the coming years’,
-
ICMR, Department of Health and Family Welfare of MoH&FW sign MoU with IVI
expressbpd
August 22, 2017
The partnership will promote further collaborative research activities and training programs between India and IVI
-
Health officials urge young people to get meningitis jab
pharmatimes
August 17, 2017
Public Health England and the Royal College of Nursing are urging new university students to get vaccinated against meningitis so that they can build immunity to the disease before fresher’s week
-
GSK inaugurates its new facility in Scotland
biospectrumasia
August 17, 2017
The facility will produce ingredients for vaccines for illnesses such as tetanus, pneumonia and whooping cough
-
Global shortage of hep B vaccine hits UK
pharmafile
August 10, 2017
tthe UK would administer all babes with the hepatitis B vaccine to reduce the risk for young children, who are most risk should they catch hep B.
-
FDA awards orphan status to new brain cancer vaccine
pharmafile
August 10, 2017
The FDA has announced that it has awarded orphan drug status to the vaccine SurVaxM for patients with glioblastoma, the most common form of brain cancer and a condition which affects 14,000 new patients in the US every month.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
